Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harrie Buist

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Regulatory Toxicology and Pharmacology : RTP|June 25, 2013
The OSIRIS Weight of Evidence approach: ITS for skin sensitisationEmiel Rorije, Tom Aldenberg, Harrie Buist, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|June 23, 2019
Derivation of safe exposure levels for potential migration of formaldehyde into foodHeinz-Peter Gelbke, Harrie Buist, Ralf Eisert, et al.
Regulatory Toxicology and Pharmacology : RTP|February 7, 2013
OSIRIS, a quest for proof of principle for integrated testing strategies of chemicals for four human health endpointsTheo Vermeire, Tom Aldenberg, Harrie Buist, et al.
Regulatory Toxicology and Pharmacology : RTP|February 27, 2013
The OSIRIS Weight of Evidence approach: ITS for the endpoints repeated-dose toxicity (RepDose ITS)Inga Tluczkiewicz, Monika Batke, Dinant Kroese, et al.
Regulatory Toxicology and Pharmacology : RTP|January 30, 2013
The OSIRIS Weight of Evidence approach: ITS mutagenicity and ITS carcinogenicityHarrie Buist, Tom Aldenberg, Monika Batke, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|September 25, 2016
Comparative Human Health Impact Assessment of Engineered Nanomaterials in the Framework of Life Cycle AssessmentWouter Fransman, Harrie Buist, Eelco Kuijpers, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
Guidance on dermal absorption, Harrie Buist, Peter Craig, et al.
Regulatory Toxicology and Pharmacology : RTP|March 12, 2008
Development of good modelling practice for physiologically based pharmacokinetic models for use in risk assessment: the first stepsGeorge Loizou, Martin Spendiff, Hugh A Barton, et al.
Reproductive Toxicology (Elmsford, N.Y.)|December 22, 2014
A high throughput screening system for predicting chemically-induced reproductive organ deformitiesBart van der Burg, Bart Pieterse, Harrie Buist, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Regulatory Toxicology and Pharmacology : RTP|June 25, 2013
The OSIRIS Weight of Evidence approach: ITS for skin sensitisationEmiel Rorije, Tom Aldenberg, Harrie Buist, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|June 23, 2019
Derivation of safe exposure levels for potential migration of formaldehyde into foodHeinz-Peter Gelbke, Harrie Buist, Ralf Eisert, et al.
Regulatory Toxicology and Pharmacology : RTP|February 7, 2013
OSIRIS, a quest for proof of principle for integrated testing strategies of chemicals for four human health endpointsTheo Vermeire, Tom Aldenberg, Harrie Buist, et al.
Regulatory Toxicology and Pharmacology : RTP|February 27, 2013
The OSIRIS Weight of Evidence approach: ITS for the endpoints repeated-dose toxicity (RepDose ITS)Inga Tluczkiewicz, Monika Batke, Dinant Kroese, et al.
Regulatory Toxicology and Pharmacology : RTP|January 30, 2013
The OSIRIS Weight of Evidence approach: ITS mutagenicity and ITS carcinogenicityHarrie Buist, Tom Aldenberg, Monika Batke, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|September 25, 2016
Comparative Human Health Impact Assessment of Engineered Nanomaterials in the Framework of Life Cycle AssessmentWouter Fransman, Harrie Buist, Eelco Kuijpers, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
Guidance on dermal absorption, Harrie Buist, Peter Craig, et al.
Regulatory Toxicology and Pharmacology : RTP|March 12, 2008
Development of good modelling practice for physiologically based pharmacokinetic models for use in risk assessment: the first stepsGeorge Loizou, Martin Spendiff, Hugh A Barton, et al.
Reproductive Toxicology (Elmsford, N.Y.)|December 22, 2014
A high throughput screening system for predicting chemically-induced reproductive organ deformitiesBart van der Burg, Bart Pieterse, Harrie Buist, et al.
Pageof 1